SkyDance Vascular

Membership Level: Standard Community

SkyDance Vascular, Inc., founded in 2017, is working to re-imagine the Peripheral Vascular Access. The OspreyIV is expected to reduce the number of known complications that result from the traditional catheter design. The company has developed several inventive improvements, including:

• Bevel Only Technique so that the needle does not penetrate past the initial entry, reducing the risk of Phlebitis and Infiltration.
• Skin Avoidance Technology, as the catheter never touches the skin, minimizing the risk of becoming infected.
• Passive Needle Retraction as the needle retracts back into the housing automatically, so that a clinician cannot get stuck.
• Contoured Directional Flow is designed to deliver fluids more efficiently while lowering the risk of both chemical and mechanical damage to provide more efficient medication delivery.

The Company is comprised of industry veterans with the required expertise to develop, commercialize, and scale the business. The executive team has successful prior experience in selling startup businesses in the vascular access space, yielding large returns for the investors. Collective backgrounds span leading medical device, enterprise software, and vascular access organizations, including St. Jude, C.R. Bard, Med-Comp, Medibuy.com, B. Braun, Vascular Pathways, Covidien, Lumitec, and Kimberly-Clark.

More